The future of discount card regulation

Retrospectiva da saúde em 2025

How AmorSaúde plans its expansion.

Advances in health plans [Omar Abujamra Junior, president of Unimed do Brasil] - Futuro Talks Spe...

Clínicas populares em expansão [Ícaro Vilar, CEO da AmorSaúde Brasil] – Futuro Talks #81

The list of hospitals and health insurance providers.

How does the ANS work?

The challenges of a hospital network

Potencial de redes hospitalares [Lício Cintra, CEO da Rede Américas] – Futuro Talks #80

VBHC and healthcare payment models

Innovations in Diagnostics [Carlos Martins, President of Roche Diagnostics] – Future Talks Specia...

New reproductive technologies - Future Explained

Value-based healthcare at Unimed

Cuidado em Saúde Baseado em Valor [Marcia Makdisse, especialista em VBHC] – Futuro Talks

Maturity of artificial intelligence

NHS Reform - Future Explained

Digital health and technological innovation [Mauricio Cerri, Unimed do Brasil] – Futuro Talks Spe...

The transformation of medical specialties

HPN: desafios da jornada ao acesso – Talks Online

Innovation in medical education [Gustavo Meirelles, Medical VP Afya] – Futuro Talks

AI should equalize knowledge and enhance skills – Thinking about the Future

The future of pharmacies in Brazil

Telesurgery and Robotic Surgery [Gualter Ramalho and Marcelo Loureiro] Future Talks Special Edition

The challenges of judicialization in health

The expansion of services in pharmacies

Farmácias como hubs de saúde [Sergio Mena Barreto, CEO da Abrafarma] – Futuro Talks

Interoperability and diagnostic medicine

The Longevity Boom - Future Explains

The role of pharmacies

A medicina diagnóstica e seu futuro [Milva Pagano, diretora executiva Abramed] – Futuro Talks

New care models for a changing society – Thinking about the Future

Regulation and research of biosimilars

Innovations in care [Lenio Alvarenga, Novartis medical director] - Futuro Talks Special Edition

Women's health: innovations and challenges – Futuro Explica

Semaglutide is now patented

Biossimilares in Brazil [Heraldo Marchezini, CEO of Biomm] – Futuro Talks

The culture of judicialization

Interoperability Challenges [Teresa Sacchetta, InterSystems dir.] – Futuro Talks Special Edition

How do public hospitals run by private institutions work? - Futuro Explica

The New Patient Experience with Digital Healthcare – Thinking About the Future

Access to new technologies and therapies

Desafios da judicialização na saúde [Daiane Lira, Conselheira do CNJ] – Futuro Talks

Cancer screening policies

What is a risk-sharing agreement? - Futuro Explica

A New Era of Hospital Quality and Safety Management – ​​Thinking About the Future

How to improve access to cancer therapies

O panorama do câncer no Brasil [Roberto de Almeida Gil, diretor do INCA] – Futuro Talks

Risks in the new drug pricing policy

Social health as a trend - Futuro Explica

How to Advance the Health Economic-Industrial Complex

Competitividade das farmacêuticas [Nelson Mussolini, presidente do Sindusfarma] – Futuro Talks

The challenge of including innovative therapies

Advances in AI regulation – Futuro Explica

Innovation in healthcare: how to identify and adopt technologies with real impact – Thinking abou...

ANS's price adjustment plan

Contexto e desafios dos planos de saúde [Bruno Sobral, dir.executivo FenaSaúde] – Futuro Talks #71

Hypercomplexity of Health Systems - Thinking about the Future

The challenges of the cancer patient's journey

Now There Are Specialists and SUS Queues - Future Explains

How to face life with cancer